TCE-RRMM

Clinical trials for TCE-RRMM explained in plain language.

Never miss a new study

Get alerted when new TCE-RRMM trials appear

Sign up with your email to follow new studies for TCE-RRMM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug elranatamab tested in Real-World chinese myeloma patients

Disease control Not yet recruiting

This study follows 159 Chinese patients with triple-class exposed relapsed/refractory multiple myeloma who are taking elranatamab in routine care. Researchers will track how well the drug controls the cancer, including response rates and survival. The goal is to see if elranatama…

Matched conditions: TCE-RRMM

Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

TCE-RRMM

Get alerted when new TCE-RRMM trials appear

New drug elranatamab tested in Real-World chinese myeloma patients